Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 735653, 7 pages
Research Article

Pharmacological Evaluation of Prosopis cineraria (L.) Druce in Gastrointestinal, Respiratory, and Vascular Disorders

1Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan
2Department of Pharmacognosy, Research Institute of Pharmaceutical Sciences, University of Karachi, Karachi 75270, Pakistan
3Department of Pharmaceutical and Biomedical Science, University of Salerno, Via Ponte don Melillo, Fisciano, 84084 Salerno, Italy

Received 13 September 2012; Accepted 13 November 2012

Academic Editor: Muhammad Nabeel Ghayur

Copyright © 2012 Khalid Hussain Janbaz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. M. Bhandari, Flora of the Indian Desert, Scientific Publishers, Jodhpur, India, 1978.
  2. A. Burkart, “A monograph of the genus Prosopis (Leguminosae, subfam. Mimosoideae),” Journal of the Arnold Arboretum, vol. 57, pp. 219–249, 1976. View at Google Scholar
  3. K. R. Kirtikar and B. D. Basu, Indian Medicinal Plants, vol. 2, International Book Distributors, Dehradun, India, 1984.
  4. K. M. Nandkarni, Indian Materia Medica, vol. 1, Popular Prakashan, Mumbai, India, 2000.
  5. C. P. Khare, Indian Medicinal Plants, Springer, Berlin, Germany, 2007.
  6. S. Gangal, S. Sharma, and A. Rauf, “Fatty acid composition of Prosopis cineraria seeds,” Chemistry of Natural Compounds, vol. 45, no. 5, pp. 705–707, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. T. Khan, N. Riaz, N. Afza et al., “Studies on the chemical constituents of Prosopis cineraria,” Journal of the Chemical Society of Pakistan, vol. 28, no. 6, pp. 619–622, 2006. View at Google Scholar · View at Scopus
  8. A. Malik and S. Kalidhar, “Phytochemical examination of Prosopis cineraria L.(druce) leaves,” Indian Journal of Pharmaceutical Sciences, vol. 69, no. 4, pp. 576–578, 2007. View at Google Scholar · View at Scopus
  9. S. Sharma and P. L. Soni, “Structural investigation of Prosopis cineraria (Kherzi) seed galactomannan,” Indian Journal of Chemistry, Section B, vol. 33, pp. 355–361, 1994. View at Google Scholar
  10. S. Robertson, N. Narayanan, and B. R. Kapoor, “Antitumour activity of Prosopis cineraria (L.) Druce against Ehrlich ascites carcinoma-induced mice,” Natural Product Research, vol. 25, no. 8, pp. 857–862, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Kumar, S. K. Yadav, S. Singh, and S. N. Pandeya, “Analgesic activity of ethanolic extract of roots of Prosopis cineraria (L.) Druce,” Journal of Applied Pharmaceutical Science, vol. 1, no. 8, pp. 158–160, 2011. View at Google Scholar
  12. V. Velmurugan, G. Arunachalam, and V. Ravichandran, “Antibacterial activity of stem bark of Prosopis cineraria (Linn.) Druce,” Archives of Applied Science Research, vol. 2, no. 4, pp. 147–150, 2010. View at Google Scholar
  13. N. Sharma, V. Garg, and A. Paul, “Antihyperglycemic, antihyperlipidemic and antioxidative potential of Prosopis cineraria bark,” Indian Journal of Clinical Biochemistry, vol. 25, no. 2, pp. 193–200, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. National Research Council, Guide for the Care and Use of Laboratory Animals, National Academy Press, Washington, DC, USA, 1996.
  15. A. H. Gilani, S. Bashir, K. H. Janbaz, and A. J. Shah, “Presence of cholinergic and calcium channel blocking activities explains the traditional use of Hibiscus rosasinensis in constipation and diarrhoea,” Journal of Ethnopharmacology, vol. 102, no. 2, pp. 289–294, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. A. H. Gilani, S. Bashir, K. H. Janbaz, and A. Khan, “Pharmacological basis for the use of Fumaria indica in constipation and diarrhea,” Journal of Ethnopharmacology, vol. 96, no. 3, pp. 585–589, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. A. J. Farre, M. Colombo, M. Fort, and B. Gutierrez, “Differential effects of various Ca2+ antagonists,” General Pharmacology, vol. 22, no. 1, pp. 177–181, 1991. View at Publisher · View at Google Scholar · View at Scopus
  18. J. M. van Rossum, “Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters,” Archives Internationales de Pharmacodynamie et de Thérapie, vol. 143, pp. 299–330, 1963. View at Google Scholar · View at Scopus
  19. T. B. Bolton, “Mechanisms of action of transmitters and other substances on smooth muscle,” Physiological Reviews, vol. 59, no. 3, pp. 606–718, 1979. View at Google Scholar · View at Scopus
  20. T. Godfraind, R. Miller, and M. Wibo, “Calcium antagonism and calcium entry blockade,” Pharmacological Reviews, vol. 38, no. 4, pp. 321–416, 1986. View at Google Scholar · View at Scopus
  21. A. Fleckenstein, “Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle,” Annual Review of Pharmacology and Toxicology, vol. 17, pp. 149–166, 1977. View at Google Scholar · View at Scopus
  22. L. L. Brunton, “Agents effecting gastrointestinal water flux and motility, emesis and anti-emetics, bile acids and pancreatic enzymes,” in Goodman and Gillman’s the Pharmacological Basis of Therapeutics, J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, and A. G. Gilman, Eds., pp. 917–936, McGraw Hill, NewYork, NY, USA, 9th edition, 1996. View at Google Scholar
  23. T. Ahmad, “Calcium antagonists: potential for asthma therapy,” Choices in Respiratory Management, vol. 22, pp. 41–43, 1992. View at Google Scholar
  24. M. N. Ghayur and A. H. Gilani, “Studies on cardio-suppressant, vasodilator and tracheal relaxant effects of Sarcococca saligna,” Archives of Pharmacal Research, vol. 29, no. 11, pp. 990–997, 2006. View at Google Scholar · View at Scopus
  25. J. Kamei and Y. Kasuya, “Antitussive effects of Ca2+ channel antagonists,” European Journal of Pharmacology, vol. 212, no. 1, pp. 61–66, 1992. View at Google Scholar · View at Scopus
  26. R. M. Graham, D. M. Perez, J. Hwa, and M. T. Piascik, “α1-adrenergic receptor subtypes molecular structure, function, and signaling,” Circulation Research, vol. 78, no. 5, pp. 737–749, 1996. View at Google Scholar · View at Scopus
  27. D. J. Triggle, “Calcium-channel antagonists: mechanisms of action, vascular selectivities, and clinical relevance,” Cleveland Clinic Journal of Medicine, vol. 59, no. 6, pp. 617–627, 1992. View at Google Scholar · View at Scopus